Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXI8NN
|
||||
| Drug Name |
6-{4-[2-(Quinolin-5-yloxy)-ethyl]-piperazin-1-ylmethyl}-4H-benzo[1,4]oxazin-3-one
|
||||
| Synonyms |
CHEMBL180182
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H26N4O3
|
||||
| Canonical SMILES |
O=C1COc2ccc(CN3CCN(CCOc4cccc5ncccc45)CC3)cc2N1
|
||||
| InChI |
InChI=1S/C24H26N4O3/c29-24-17-31-23-7-6-18(15-21(23)26-24)16-28-11-9-27(10-12-28)13-14-30-22-5-1-4-20-19(22)3-2-8-25-20/h1-8,15H,9-14,16-17H2,(H,26,29)
|
||||
| InChIKey |
IHTZUVIXLUJIBZ-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.